Mitochondrial dysfunction: An early event in Alzheimer pathology accumulates with age in AD transgenic mice
暂无分享,去创建一个
M. Jendrach | U. Brandt | A. Eckert | S. Dröse | S. Hauptmann | I. Scherping | K. Leuner | K. Schulz | K. Schulz | K. Leuner | W. Müller | Walter E. Müller | Walter E. Müller
[1] P. Moreira,et al. Alzheimer's disease: a lesson from mitochondrial dysfunction. , 2007, Antioxidants & redox signaling.
[2] Gabriele Siciliano,et al. Mitochondrial cascade hypothesis of Alzheimer's disease: myth or reality? , 2007, Antioxidants & redox signaling.
[3] Reham M. Abdel-Kader,et al. Mitochondrial dysfunction: the first domino in brain aging and Alzheimer's disease? , 2007, Antioxidants & redox signaling.
[4] J. Brion,et al. Calcium-mediated Transient Phosphorylation of Tau and Amyloid Precursor Protein Followed by Intraneuronal Amyloid-β Accumulation* , 2006, Journal of Biological Chemistry.
[5] W. Müller,et al. Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease , 2006, Experimental Gerontology.
[6] X. Chen,et al. Mitochondrial Aβ: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease , 2005 .
[7] A. Navarro,et al. Vitamin E at high doses improves survival, neurological performance, and brain mitochondrial function in aging male mice. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[8] J. Mazat,et al. Gradual Alteration of Mitochondrial Structure and Function by β-Amyloids: Importance of Membrane Viscosity Changes, Energy Deprivation, Reactive Oxygen Species Production, and Cytochrome c Release , 2005, Journal of bioenergetics and biomembranes.
[9] R. Ravid,et al. Proteomic and Functional Analyses Reveal a Mitochondrial Dysfunction in P301L Tau Transgenic Mice* , 2005, Journal of Biological Chemistry.
[10] P. Hammerstein,et al. Morpho-dynamic changes of mitochondria during ageing of human endothelial cells , 2005, Mechanisms of Ageing and Development.
[11] T. Bayer,et al. Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice , 2005, Neurobiology of Disease.
[12] M. Nieto,et al. Nitric oxide in the cerebral cortex of amyloid-precursor protein (SW) Tg2576 transgenic mice , 2004, Neuroscience.
[13] C. Haass,et al. Amyloid β-induced Changes in Nitric Oxide Production and Mitochondrial Activity Lead to Apoptosis* , 2004, Journal of Biological Chemistry.
[14] G. Perry,et al. Drug therapy in Alzheimer's disease [5] (multiple letters) , 2004 .
[15] M. Bauer,et al. Significance of Respirasomes for the Assembly/Stability of Human Respiratory Chain Complex I* , 2004, Journal of Biological Chemistry.
[16] M. Mattson. Pathways towards and away from Alzheimer's disease , 2004, Nature.
[17] R. Martínez-Murillo,et al. Intra- and extracellular Abeta and PHF in clinically evaluated cases of Alzheimer's disease. , 2004, Histology and histopathology.
[18] Xi Chen,et al. Materials and Methods Som Text Figs. S1 and S2 Table S1 References Abad Directly Links A to Mitochondrial Toxicity in Alzheimer's Disease , 2022 .
[19] A. Navarro,et al. Beneficial effects of moderate exercise on mice aging: survival, behavior, oxidative stress, and mitochondrial electron transfer. , 2004, American journal of physiology. Regulatory, integrative and comparative physiology.
[20] I. Santana,et al. Cytochrome c oxidase is decreased in Alzheimer’s disease platelets , 2004, Neurobiology of Aging.
[21] T. Bayer,et al. Time sequence of maturation of dystrophic neurites associated with Aβ deposits in APP/PS1 transgenic mice , 2003, Experimental Neurology.
[22] Anne Eckert,et al. Mitochondrial dysfunction, apoptotic cell death, and Alzheimer's disease. , 2003, Biochemical pharmacology.
[23] A. Baracca,et al. Rhodamine 123 as a probe of mitochondrial membrane potential: evaluation of proton flux through F(0) during ATP synthesis. , 2003, Biochimica et biophysica acta.
[24] J. Blass. Cerebrometabolic abnormalities in Alzheimer's disease , 2003, Neurological research.
[25] L. Murri,et al. Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease , 2003, Experimental Neurology.
[26] C. Haass,et al. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation , 2003, Journal of Biological Chemistry.
[27] F. LaFerla. Calcium dyshomeostasis and intracellular signalling in alzheimer's disease , 2002, Nature Reviews Neuroscience.
[28] C. Haass,et al. Reduction of trophic support enhances apoptosis in PC12 cells expressing Alzheimer’s APP mutation and sensitizes cells to staurosporine-induced cell death , 2002, Journal of Molecular Neuroscience.
[29] Gabriele Siciliano,et al. Cytochrome c oxidase and mitochondrial F1F0-ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer’s disease , 2002, Neurobiology of Aging.
[30] W. Müller,et al. Membrane-disordering effects of β-amyloid peptides , 2001 .
[31] C. Haass,et al. Elevated vulnerability to oxidative stress‐induced cell death and activation of caspase‐3 by the Swedish amyloid precursor protein mutation , 2001, Journal of neuroscience research.
[32] S. Hoyer. Brain glucose and energy metabolism abnormalities in sporadic Alzheimer disease. Causes and consequences: an update , 2000, Experimental Gerontology.
[33] U. F. Rasmussen,et al. Human quadricepts muscle mitochondria: A functional characterization , 2000, Molecular and Cellular Biochemistry.
[34] A. Nunomura,et al. Mitochondrial abnormalities in Alzheimer disease , 2000, Neurobiology of Aging.
[35] T. Bates,et al. β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria , 1999, FEBS letters.
[36] A. Baracca,et al. The effect of aging and an oxidative stress on peroxide levels and the mitochondrial membrane potential in isolated rat hepatocytes , 1999, FEBS letters.
[37] Y. Kitamura,et al. Alteration of proteins regulating apoptosis, Bcl-2, Bcl-x, Bax, Bak, Bad, ICH-1 and CPP32, in Alzheimer's disease , 1998, Brain Research.
[38] M. Esiri,et al. Apoptosis-Related Protein Expression in the Hippocampus in Alzheimer’s Disease , 1997, Neurobiology of Aging.
[39] D. Selkoe. Images in neuroscience. Alzheimer's disease: from genes to pathogenesis. , 1997, The American journal of psychiatry.
[40] P. Gluckman,et al. Bax expression in mammalian neurons undergoing apoptosis, and in Alzheimer's disease hippocampus , 1997, Brain Research.
[41] C. Cotman,et al. Bax Protein Expression Is Increased in Alzheimer's Brain: Correlations with DNA Damage, Bcl‐2 Expression, and Brain Pathology , 1997, Journal of neuropathology and experimental neurology.
[42] P. Chagnon,et al. Distribution of brain cytochrome oxidase activity in various neurodegenerative diseases. , 1995, Neuroreport.
[43] J. Dykens. Isolated Cerebral and Cerebellar Mitochondria Produce Free Radicals when Exposed to Elevated Ca2+ and Na+: Implications for Neurodegeneration , 1994, Journal of neurochemistry.
[44] M. Mattson,et al. A model for beta-amyloid aggregation and neurotoxicity based on free radical generation by the peptide: relevance to Alzheimer disease. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[45] J. Miquel,et al. Age-related changes in glutathione and lipid peroxide content in mouse synaptic mitochondria: Relationship to cytochrome c oxidase decline , 1994, Neuroscience Letters.
[46] J. Nobrega,et al. Brain Cytochrome Oxidase in Alzheimer's Disease , 1992, Journal of neurochemistry.
[47] Oliver H. Lowry,et al. Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.
[48] H. Schägger,et al. Blue native PAGE , 2006, Nature Protocols.
[49] J. Blass,et al. The role of the metabolic lesion in Alzheimer's disease. , 2002, Journal of Alzheimer's disease : JAD.
[50] B. Van Houten,et al. Measuring oxidative mtDNA damage and repair using quantitative PCR. , 2002, Methods in molecular biology.
[51] S. Leutner,et al. ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain , 2001, Journal of Neural Transmission.
[52] L. Packer,et al. Mitochondrial dysfunction in the senescence accelerated mouse (SAM). , 1998, Free radical biology & medicine.
[53] R. Kozłowski,et al. The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. , 1993, Journal of immunological methods.